Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant Occludin antibody

The Rabbit Monoclonal anti-Occludin antibody has been validated for IHC, ELISA and FACS. It is suitable to detect Occludin in samples from Human.
Catalog No. ABIN7609875

Quick Overview for Recombinant Occludin antibody (ABIN7609875)

Target

See all Occludin (OCLN) Antibodies
Occludin (OCLN)

Antibody Type

Recombinant Antibody

Reactivity

  • 126
  • 64
  • 44
  • 34
  • 18
  • 12
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
Human

Host

  • 95
  • 39
  • 3
  • 1
Rabbit

Clonality

  • 90
  • 48
Monoclonal

Conjugate

  • 63
  • 11
  • 6
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
This Occludin antibody is un-conjugated

Application

  • 106
  • 46
  • 36
  • 31
  • 26
  • 26
  • 20
  • 20
  • 17
  • 15
  • 13
  • 6
  • 2
  • 2
  • 1
  • 1
Immunohistochemistry (IHC), ELISA, Flow Cytometry (FACS)

Clone

8H8
  • Expression System

    HEK-293F Cells

    Purpose

    Ocln Recombinant Antibody

    Characteristics

    The Ocln Recombinant Antibody (Species: Human) has been validated for the following applications: ELISA, IHC, FC.

    Purification

    Affinity-Chromatography

    Immunogen

    A Synthesized Peptide Derived From Human Ocln

    Isotype

    IgG
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    Rabbit IgG in Phosphate Buffered Saline, pH 7.4, 150 mM NaCl, 0.02 % Sodium Azide and 50 % Glycerol

    Storage

    4 °C,-20 °C

    Storage Comment

    2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.

    Expiry Date

    12 months
  • Target

    Occludin (OCLN)

    Alternative Name

    OCLN

    UniProt

    Q16625

    Pathways

    Cell-Cell Junction Organization, Hepatitis C
You are here:
Chat with us!